As part of the agreement, Mayo Clinic will help the company advance its point of care molecular analyzer technology dubbed the Genomadix Cube, according to an Aug. 29 press release.
The Genomadix Cube uses polymerase chain reaction technology in a portable footprint to generate timely test results.
According to the press release, any revenue the technology generates will go toward supporting Mayo Clinic’s patient care, education and research.
“We are extremely proud to be collaborating with Mayo Clinic to progress our technology and mission to make highly accurate molecular testing available for the benefit of patients,” said Steve Edgett, CEO of Genomadix. “This collaboration seeks to seed new product developments with focused expertise provided by Mayo Clinic experts.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
